DMC Powder
DMC Powder Price range: € 45,90 through € 1.395,00
Back to products
1cP-MiPLA Blotters 200mcg research material from Raw Lab Chems
Buy 1cP-MiPLA Blotters - 200mcg Price range: € 43,30 through € 515,00

1B-LSD Blotters – 125mcg

Price range: € 31,75 through € 370,00

1B-LSD Blotters 125mcg are described as blotter-paper research preparations associated with 1-butanoyl-lysergic acid diethylamide, an N1-acylated derivative of LSD.

The named compound belongs to the lysergamide family and is distinguished from LSD by a butanoyl substituent at the indole nitrogen.

The supplied source identifies perforated blotter-paper squares with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.

Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and investigation of related lysergamides.

The source reports a CAS number, molecular formula, molecular weight, and systematic name, but these identifiers require reconciliation with the intended 1-butanoyl compound.

It also refers to third-party analytical verification, Certificate of Analysis documentation, batch tracking, and ISO-compliant manufacturing.

However, no actual batch-specific certificate, independent laboratory report, or manufacturing certification was supplied.

Ingredient purity, finished-unit analyte content, content uniformity, substrate composition, chemical form, and storage stability remain unverified.

The blotters are not established as certified reference materials or validated quantitative calibration standards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12844 Category:
Description

1B-LSD Blotters 125mcg – Butanoyl Lysergamide Research Material

1B-LSD Blotters 125mcg – Product Overview

1B-LSD Blotters 125mcg is the supplied catalog designation for a blotter-format research preparation associated with 1-butanoyl-LSD.

The named compound belongs to the lysergamide family and is structurally related to lysergic acid diethylamide.

Its molecular structure differs from LSD through the presence of a butanoyl substituent at the indole nitrogen.

The supplied source presents the product as perforated blotter-paper squares intended for controlled analytical and non-clinical laboratory research.

Each finished blotter is described as having a labeled analyte quantity.

However, no actual finished-unit assay or content-uniformity report accompanied the information.

The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.

The supplied scientific context includes chemical identification, chromatographic characterization, structural comparison, and stability-focused investigation.

These research contexts should be distinguished from verified findings about the actual finished blotters.

No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.

The source also refers to independent analytical verification, batch identification, and Certificate of Analysis documentation.

These statements remain unverified without supporting records.

The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.

Chemical Identity & Classification

The supplied source identifies 1B-LSD as 1-butanoyl-lysergic acid diethylamide.

It is an N1-acylated lysergamide structurally related to LSD.

The butanoyl substituent distinguishes the named compound from LSD and other N1-acylated derivatives.

The supplied chemical information includes:

  • Common designation: 1B-LSD
  • Descriptive chemical name: 1-Butanoyl-lysergic acid diethylamide
  • Reported CAS Registry Number: 2349358-81-0; requires verification
  • Reported molecular formula: C24H31N3O2
  • Calculated molecular weight from reported formula: Approximately 393.53 g/mol
  • Chemical classification: N1-acylated lysergamide
  • Reported presentation: Perforated blotter-paper squares
  • Labeled analyte amount: Specified per finished blotter
  • Intended designation: Research Use Only

The source also supplies a systematic name containing a propionyl substituent.

That naming conflicts with the description of 1B-LSD as a butanoyl derivative.

The supplied CAS number likewise requires confirmation against the intended molecular structure.

Although the reported molecular formula and molecular weight are internally consistent, this does not establish that they correctly describe 1B-LSD.

The chemical identifiers should be reconciled using verified structural documentation before publication.

No batch-specific salt-form determination or complete stereochemical characterization was supplied.

The molecular structure of the named compound does not establish the composition of the finished blotter preparation.

Additional substrate materials or formulation components may be present, but the source does not identify them.

Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual molecular structure, stereochemistry, and chemical form being examined.

Chemical & Physical Characteristics

The supplied source describes the product as perforated blotter-paper squares.

No actual product-specific physical inspection report, image verification, or batch appearance record was supplied.

A blotter is a finished preparation in which the named analyte is associated with a carrier substrate.

The characteristics of the complete preparation therefore differ from those of the isolated chemical compound.

The source does not identify the substrate composition, blotter dimensions, total unit mass, manufacturing method, or surface characteristics.

The named compound is described as containing a butanoyl substituent attached to the lysergamide framework.

This structural feature distinguishes 1B-LSD from LSD and from related derivatives containing different N1-acyl groups.

The source does not provide experimentally verified solubility measurements or product-specific solvent compatibility records.

It also does not supply a substrate-extraction study or analytical recovery assessment.

The absence of these records prevents any definitive claim about extraction performance or analytical recovery from the finished blotters.

The source does not establish the distribution of analyte across the blotter substrate.

Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.

Purity & Analytical Verification

The supplied source claims ingredient purity of at least 98% and refers to third-party verification.

However, no actual batch-specific Certificate of Analysis or independent laboratory report accompanied that statement.

The reported purity therefore remains a supplier-provided claim rather than an independently verified result.

The source refers to HPLC, GC-MS, NMR spectroscopy, and LC-MS as analytical techniques relevant to chemical characterization.

No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.

Accordingly, no specific purity result can be confirmed for the actual product batch.

For 1B-LSD Blotters 125mcg, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.

An ingredient-purity result does not independently establish finished-unit content or content uniformity.

The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.

The material is described in reference-oriented research terms.

However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.

The finished blotters should therefore not be represented as certified quantitative reference standards.

Any definitive analytical claims require actual supporting batch records.

Quality Control & Batch Integrity

The supplied source refers to third-party testing, batch identification, full documentation, and ISO-compliant production conditions.

These statements describe claimed quality-assurance practices.

No actual certificate, independent testing report, manufacturing audit, ISO certificate, or batch-specific quality-control record accompanied the information.

They therefore remain unverified supplier claims.

For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.

For 1B-LSD Blotters 125mcg, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.

The supplied information does not establish independently verified analyte content, substrate composition, or content uniformity.

The source also does not provide evidence that every finished blotter meets a particular quantitative specification.

The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.

Claims concerning batch consistency, independent testing, ISO compliance, and validated analytical performance should be supported by actual records.

Safety, Handling & Laboratory Precautions

1B-LSD is a synthetic lysergamide associated with potential pharmacological activity and toxicological uncertainty.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The blotter presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual chemical form, ingredient purity, substrate composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes discreet packaging, batch-aware handling, tracking, and professional shipment arrangements.  1B-LSD Blotters 125mcg

No actual packaging specification, container-validation report, or shipment-condition record was provided.

The source recommends storage in a cool, dry environment protected from light.

It also suggests refrigeration at approximately 2–8°C.

No validated product-specific stability study was supplied to establish that temperature range as a verified requirement or to support a particular shelf life.

For 1B-LSD Blotters 125mcg, laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 1B-LSD within analytical research involving lysergamide chemical identity, N1-acyl substitution, and comparative structural characterization.

The butanoyl substituent provides a distinguishing structural feature relevant to chemical analysis.

The source also describes interest in chromatographic profiling, forensic analytical characterization, and stability-focused laboratory research.

However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual blotters.  1B-LSD Blotters 125mcg

The Raw Lab Chems catalog identifies 1B-LSD Blotters as the product listing discussed here.

For related chemical-family and presentation context, the supplied catalog also includes 1V-LSD Pellets and 1B-LSD-series Blotters.

The first related listing refers to a different N1-acylated lysergamide.

The second is a separately named catalog preparation whose exact chemical identity should be confirmed from its own product documentation.

These preparations should not be treated as chemically identical or analytically interchangeable without verified supporting evidence.

The supplied information does not establish equivalent chemical purity, analyte content, substrate composition, excipient composition, or content uniformity across these preparations.

These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.

Ordering, Availability & Fulfillment

The supplied source describes professional packaging, international shipping, tracking, and secure handling arrangements.  1B-LSD Blotters 125mcg

No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

Consequently, no availability, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.

1B-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.

Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.

Research-only labeling does not establish a legal exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.  1B-LSD Blotters 125mcg

1B-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (blotters)

5

,

10

,

25

,

50

,

100

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “1B-LSD Blotters – 125mcg”
Shipping & Delivery